AU3479699A - A polypeptide comprising the amino acid of an n-terminal choline binding proteina truncate, vaccine derived therefrom and uses thereof - Google Patents
A polypeptide comprising the amino acid of an n-terminal choline binding proteina truncate, vaccine derived therefrom and uses thereofInfo
- Publication number
- AU3479699A AU3479699A AU34796/99A AU3479699A AU3479699A AU 3479699 A AU3479699 A AU 3479699A AU 34796/99 A AU34796/99 A AU 34796/99A AU 3479699 A AU3479699 A AU 3479699A AU 3479699 A AU3479699 A AU 3479699A
- Authority
- AU
- Australia
- Prior art keywords
- proteina
- truncate
- polypeptide
- amino acid
- derived therefrom
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 title 1
- 229960001231 choline Drugs 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 150000003248 quinolines Chemical group 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8087898P | 1998-04-07 | 1998-04-07 | |
| US09/056,019 US6858706B2 (en) | 1998-04-07 | 1998-04-07 | Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
| US09056019 | 1998-04-07 | ||
| US60080878 | 1998-04-07 | ||
| PCT/US1999/007668 WO1999051187A2 (en) | 1998-04-07 | 1999-04-07 | A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3479699A true AU3479699A (en) | 1999-10-25 |
Family
ID=26734874
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU34796/99A Withdrawn AU3479699A (en) | 1998-04-07 | 1999-04-07 | A polypeptide comprising the amino acid of an n-terminal choline binding proteina truncate, vaccine derived therefrom and uses thereof |
| AU34797/99A Ceased AU764811B2 (en) | 1998-04-07 | 1999-04-07 | A polypeptide comprising the amino acid of an n-terminal choline binding protein A truncate, vaccine derived therefrom and uses thereof |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU34797/99A Ceased AU764811B2 (en) | 1998-04-07 | 1999-04-07 | A polypeptide comprising the amino acid of an n-terminal choline binding protein A truncate, vaccine derived therefrom and uses thereof |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JP4739521B2 (enExample) |
| KR (1) | KR100638503B1 (enExample) |
| CN (1) | CN1191851C (enExample) |
| AU (2) | AU3479699A (enExample) |
| BR (1) | BR9909910A (enExample) |
| CA (1) | CA2326388C (enExample) |
| HU (1) | HUP0102306A3 (enExample) |
| IL (1) | IL138939A0 (enExample) |
| MX (1) | MXPA00009899A (enExample) |
| NO (1) | NO20005081L (enExample) |
| NZ (1) | NZ507983A (enExample) |
| PL (1) | PL193132B1 (enExample) |
| TR (1) | TR200003498T2 (enExample) |
| WO (1) | WO1999051188A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0022742D0 (en) | 2000-09-15 | 2000-11-01 | Smithkline Beecham Biolog | Vaccine |
| TWI457133B (zh) | 2005-12-13 | 2014-10-21 | Glaxosmithkline Biolog Sa | 新穎組合物 |
| GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
| CA2808919C (en) | 2005-12-22 | 2016-04-19 | Glaxosmithkline Biologicals S.A. | Streptococcus pneumoniae capsular saccharide vaccine |
| KR101579947B1 (ko) | 2007-06-26 | 2015-12-28 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 스트렙토코쿠스 뉴모니애 캡슐 다당류 컨쥬게이트를 포함하는 백신 |
| WO2009127676A1 (en) | 2008-04-16 | 2009-10-22 | Glaxosmithkline Biologicals S.A. | Vaccine |
| GB201003924D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| AU2012257771C1 (en) | 2011-05-17 | 2015-12-03 | Glaxosmithkline Biologicals S.A. | Vaccine against Streptococcus pneumoniae |
| GB201518684D0 (en) | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Vaccine |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6592876B1 (en) * | 1993-04-20 | 2003-07-15 | Uab Research Foundation | Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products |
| WO1997041151A2 (en) * | 1996-05-01 | 1997-11-06 | The Rockefeller University | Choline binding proteins for anti-pneumococcal vaccines |
| DE69739981D1 (de) * | 1996-10-31 | 2010-10-14 | Human Genome Sciences Inc | Streptococcus pneumoniae-Antigene und Impfstoffe |
| AU5355398A (en) * | 1996-11-12 | 1998-06-03 | Regents Of The University Of Minnesota | C3 binding protein of (streptococcus pneumoniae) |
| US6858706B2 (en) * | 1998-04-07 | 2005-02-22 | St. Jude Children's Research Hospital | Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
| DE69942176D1 (de) * | 1998-04-07 | 2010-05-06 | Medimmune Llc | Choline-bindende proteine derivate aus pneumokoken als impfstoff |
-
1999
- 1999-04-07 HU HU0102306A patent/HUP0102306A3/hu unknown
- 1999-04-07 TR TR2000/03498T patent/TR200003498T2/xx unknown
- 1999-04-07 AU AU34796/99A patent/AU3479699A/en not_active Withdrawn
- 1999-04-07 KR KR1020007011206A patent/KR100638503B1/ko not_active Expired - Fee Related
- 1999-04-07 CA CA2326388A patent/CA2326388C/en not_active Expired - Fee Related
- 1999-04-07 MX MXPA00009899A patent/MXPA00009899A/es unknown
- 1999-04-07 PL PL347946A patent/PL193132B1/pl unknown
- 1999-04-07 CN CNB998108545A patent/CN1191851C/zh not_active Expired - Fee Related
- 1999-04-07 JP JP2000541960A patent/JP4739521B2/ja not_active Expired - Fee Related
- 1999-04-07 AU AU34797/99A patent/AU764811B2/en not_active Ceased
- 1999-04-07 NZ NZ507983A patent/NZ507983A/xx not_active IP Right Cessation
- 1999-04-07 BR BR9909910-1A patent/BR9909910A/pt not_active Application Discontinuation
- 1999-04-07 IL IL13893999A patent/IL138939A0/xx unknown
- 1999-04-07 WO PCT/US1999/007669 patent/WO1999051188A2/en not_active Ceased
-
2000
- 2000-10-09 NO NO20005081A patent/NO20005081L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NZ507983A (en) | 2004-03-26 |
| KR100638503B1 (ko) | 2006-10-26 |
| BR9909910A (pt) | 2002-01-15 |
| WO1999051188A9 (en) | 2000-10-12 |
| HUP0102306A3 (en) | 2008-04-28 |
| CN1191851C (zh) | 2005-03-09 |
| CA2326388C (en) | 2014-02-04 |
| NO20005081D0 (no) | 2000-10-09 |
| CN1342088A (zh) | 2002-03-27 |
| PL193132B1 (pl) | 2007-01-31 |
| CA2326388A1 (en) | 1999-10-14 |
| AU3479799A (en) | 1999-10-25 |
| HUP0102306A1 (hu) | 2001-09-28 |
| NO20005081L (no) | 2000-12-06 |
| MXPA00009899A (es) | 2002-05-08 |
| PL347946A1 (en) | 2002-04-22 |
| IL138939A0 (en) | 2001-11-25 |
| TR200003498T2 (tr) | 2001-10-22 |
| AU764811B2 (en) | 2003-08-28 |
| KR20010052244A (ko) | 2001-06-25 |
| WO1999051188A3 (en) | 2001-04-19 |
| JP4739521B2 (ja) | 2011-08-03 |
| WO1999051188A2 (en) | 1999-10-14 |
| JP2002516662A (ja) | 2002-06-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0003533A3 (en) | Interleukin-18 binding proteins, their preparation and use | |
| WO2000023472A3 (en) | Interferon-beta fusion proteins and uses | |
| AU2001286730A1 (en) | An iap binding peptide or polypeptide and methods of using the same | |
| AU2002217010A1 (en) | Peptides, the production and use thereof for binding immunoglobulins | |
| ZA200006309B (en) | A polypeptide comprising the amino acid of an n-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof. | |
| AU3479699A (en) | A polypeptide comprising the amino acid of an n-terminal choline binding proteina truncate, vaccine derived therefrom and uses thereof | |
| AU5789499A (en) | (neisseria meningitidis) polypeptide, nucleic acid sequence and uses thereof | |
| AU2002233457A1 (en) | Non-glycosylated peptides derived from the rsv g protein and use thereof in a vaccine | |
| AU5031598A (en) | Immune-modulation with amino acids | |
| AU2000275748A1 (en) | Hla-a2.1 binding peptides and their uses | |
| EP1181315A4 (en) | LAWSONIA DERIVATIVE GENE, FLGE POLYPEPTIDES, PEPTIDES AND PROTEINS AND USES THEREOF | |
| AU6301698A (en) | Anti-hiv peptides and proteins | |
| AU3735095A (en) | Compositions containing a p53 derived protein or peptide, an adjuvant, and interleukin-12 and uses thereof | |
| AU2002221428A1 (en) | Novel polypeptide human polyadenylation binding protein 20.13 and polynucleotideencoding it | |
| AU8748101A (en) | A novel polypeptide, a human protein stat2 and the polynucleotide encoding the polypeptide | |
| AU1983601A (en) | A novel ribosomal s9 protein 26 and the polypeptide encoding thereof | |
| AU2002245311A1 (en) | Human protein kinase n-like polypeptide and uses thereof | |
| IL135987A0 (en) | Lysozyme analogous proteins and peptides, processes for the preparation thereof and compositions and methods utilizing the same | |
| AU2002341023A1 (en) | Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses | |
| AU8953301A (en) | A novel polypeptide, a zinc-finger protein 34 and the polynucleotide encoding the polypeptide | |
| AU4404401A (en) | A novel polypeptide, human pax protein 9 and the polynucleotide encoding thereof | |
| AU6727101A (en) | A novel polypeptide, a human pax protein 17 and the polynucleotide encoding the polypeptide | |
| AU2003200442A1 (en) | Interleukin-18 binding proteins, their preparation and use | |
| AU7898700A (en) | A novel polypeptide-rna binding protein 33 and polynucleotide encoding said polypeptide | |
| AU2002223373A1 (en) | A novel polypeptide-the human retinoblastoma binding protein 19.91 and the polynucleotide encoding said polypeptide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK13 | Application withdrawn section 141(2)/reg 8.3(2) - pct appl. non-entering nat. phase, withdrawn by applicant |